抄録
HIV-1 TAT peptide, which is a cell-penetrating peptide (CPP), was fused to the U1A RNA-binding domain (TatU1A) to generate a sequence-specific siRNA delivery system for mammalian cells. The siRNA contained a short 5′-extension that is specifically recognized by the U1A RNA-binding domain (U1AsiRNA). Specific binding of TatU1A to the U1AsiRNA was confirmed using a gel mobility shift assay. The U1AsiRNA was internalized by cells only when it was preincubated with TatU1A before addition to the cells. Although most of the internalized siRNA seemed to be entrapped in endocytic compartments, efficient redistribution of the entrapped siRNAs was achieved by photostimulation of a fluorophore attached to TatU1A. Once in the cytoplasm, the siRNA induced RNAi-mediated gene silencing. We refer to this delivery strategy as CLIP-RNAi. CLIP-RNAi is a promising strategy for RNAi experiments and for pinpoint RNAi therapy.
本文言語 | English |
---|---|
ページ(範囲) | 1017-1024 |
ページ数 | 8 |
ジャーナル | Bioconjugate Chemistry |
巻 | 19 |
号 | 5 |
DOI | |
出版ステータス | Published - 5月 2008 |
ASJC Scopus subject areas
- バイオテクノロジー
- バイオエンジニアリング
- 生体医工学
- 薬理学
- 薬科学
- 有機化学